Genotype-phenotype associations in individuals with Diamond Blackfan anaemia.

Autor: Gianferante DM; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics National Cancer Institute, NIH, Rockville Bethesda Maryland USA.; Department of Pediatrics Uniformed Services University of the Health Sciences Bethesda Maryland USA., Mendez KJW; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics National Cancer Institute, NIH, Rockville Bethesda Maryland USA., Cole S; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics National Cancer Institute, NIH, Rockville Bethesda Maryland USA.; Department of Pediatrics Uniformed Services University of the Health Sciences Bethesda Maryland USA.; Department of Cancer Epidemiology and Genetics Walter Reed National Military Medical Center Bethesda Maryland USA., Gadalla SM; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics National Cancer Institute, NIH, Rockville Bethesda Maryland USA., Alter BP; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics National Cancer Institute, NIH, Rockville Bethesda Maryland USA., Savage SA; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics National Cancer Institute, NIH, Rockville Bethesda Maryland USA., Giri N; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics National Cancer Institute, NIH, Rockville Bethesda Maryland USA.
Jazyk: angličtina
Zdroj: EJHaem [EJHaem] 2024 Oct 16; Vol. 5 (6), pp. 1117-1124. Date of Electronic Publication: 2024 Oct 16 (Print Publication: 2024).
DOI: 10.1002/jha2.1031
Abstrakt: Introduction: Diamond Blackfan anaemia (DBA) is a rare disorder characterized by failure of red blood cell production, congenital abnormalities and cancer predisposition, primarily caused by pathogenic germline variants in genes encoding ribosomal proteins.
Methods: We conducted a genotype-phenotype and outcome study of 121 patients with DBA spanning the 20-year history of the National Cancer Institute's Inherited Bone Marrow Failure Syndromes study. Patient phenotypes were compared by large versus small ribosomal protein genes, across genes with >5 cases ( RPS19 , RPS29 , RPS26 and RPL35A ) and by type of pathogenic variants (hypomorphic versus null, large deletions versus others).
Results: A pathogenic germline variant was identified in 71% of patients ( n  = 86/121) from 54 families. After adjusting for multiple testing, we found that patients with RPS29 variants were least likely to need treatment for anaemia while those with large ribosomal protein subunit variants had a higher proportion of intellectual disability and gastrointestinal abnormalities compared with small ribosomal protein subunit variants ( p  < 3.5 × 10 -4 ). There were no statistically significant differences in overall survival or cancer incidence among patients with large or small ribosomal subunit genes.
Conclusion: This detailed genotype-phenotype study of DBA improves our understanding of the role of germline genetics in the clinical manifestations that may help guide the management of people with DBA.
Competing Interests: The authors declare no conflict of interest.
(Published 2024. This article is a U.S. Government work and is in the public domain in the USA. eJHaem published by British Society for Haematology and John Wiley & Sons Ltd.)
Databáze: MEDLINE
Externí odkaz: